Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 04 Jan 2022

Integrated Transcriptomic Analysis Reveals a Distinctive Role of YAP1 in Extramedullary Invasion and Therapeutic Sensitivity of Multiple Myeloma

in Hematologic Malignancies

Bo Zheng
Wei Sun
Ke Yi
Yajun Zhang
Liangzhe Wang
Hongyan Lan
Chong Zhang
Hongming Xian
Rong Li

Frontiers in Oncology

doi 10.3389/fonc.2021.787814

6,518 views
8 citations

Original Research

Published on 04 Jan 2022

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study

in Hematologic Malignancies

Meng Wu
Yun Li
Huiqiang Huang
Wei Xu
Yanyan Wang
Haiwen Huang
Weili Zhao
Shuo Liu
Pengpeng Xu
Zhengming Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.770988

6,304 views
7 citations

Case Report

Published on 03 Jan 2022

Therapeutic Effect of CAOLD Chemotherapy Regimen on Patients With Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: A Case Study

in Hematologic Malignancies

Yu Liu
Pingping Li
Liren Qian

Frontiers in Oncology

doi 10.3389/fonc.2021.758445

3,503 views
2 citations

Review

Published on 03 Jan 2022

The Elephant in The Room: AML Relapse Post Allogeneic Hematopoietic Cell Transplantation

in Hematologic Malignancies

Iman Abou Dalle
Ali Atoui
Ali Bazarbachi

Frontiers in Oncology

doi 10.3389/fonc.2021.793274

14,245 views
11 citations

Retraction

Published on 30 Dec 2021

Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis

in Hematologic Malignancies

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2021.840086

9,278 views

Case Report

Published on 24 Dec 2021

Case Report: Opposite Effects of BRAF Inhibition on Closely Related Clonal Myeloid Disorders

in Hematologic Malignancies

Katrin E. Hostettler
Elisa Casañas Quintana
Michael Tamm
Spasenija Savic Prince
Gregor Sommer
Wei-Chih Chen
Thierry Michael Nordmann
Pontus Lundberg
Gregor Thomas Stehle
Thomas Daikeler

Frontiers in Oncology

doi 10.3389/fonc.2021.779523

4,484 views
2 citations

Original Research

Published on 24 Dec 2021

Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies

in Hematologic Malignancies

Jian Han
Lu Liu
Li Meng
Huan Guo
Jin Zhang
Zhi-Qiang Han
Zhen-Ya Hong

Frontiers in Oncology

doi 10.3389/fonc.2021.759805

3,692 views
14 citations

Case Report

Published on 23 Dec 2021

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

in Hematologic Malignancies

Hui Liu
Qi Shen
Chung-Che Chang
Shimin Hu

Frontiers in Oncology

doi 10.3389/fonc.2021.795330

3,572 views
2 citations

Mini Review

Published on 23 Dec 2021

The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia

in Hematologic Malignancies

Chun-fung Sin
Pui-hei Marcus Man

Frontiers in Oncology

doi 10.3389/fonc.2021.802832

6,666 views
17 citations

Original Research

Published on 22 Dec 2021

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target

in Hematologic Malignancies

Noa G. Holtzman
Michael S. Lebowitz
Rima Koka
Maria R. Baer
Kanam Malhotra
Amir Shahlaee
Hossein A. Ghanbari
Søren M. Bentzen
Ashkan Emadi

Frontiers in Oncology

doi 10.3389/fonc.2021.783744

4,032 views
5 citations

Original Research

Published on 21 Dec 2021

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

in Hematologic Malignancies

Yingxin Sun
Yifeng Cai
Jiannong Cen
Mingqing Zhu
Jinlan Pan
Qian Wang
Depei Wu
Suning Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.797825

10,462 views
7 citations

Perspective

Published on 21 Dec 2021

The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia

in Hematologic Malignancies

Antonella Nicolò
Alexandra Theresa Linder
Hassan Jumaa
Palash Chandra Maity

Frontiers in Oncology

doi 10.3389/fonc.2021.771669

3,970 views
3 citations

Original Research

Published on 20 Dec 2021

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group

in Hematologic Malignancies

Kun-yin Qiu
Hong-gui Xu
Xue-qun Luo
Hui-rong Mai
Ning Liao
Li-hua Yang
Min-cui Zheng
Wu-qing Wan
Xue-dong Wu
Ri-yang Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.797194

10,374 views
22 citations

Original Research

Published on 17 Dec 2021

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients

in Hematologic Malignancies

Tao Wang
Wenqin Yue
Gusheng Tang
Mingyu Ye
Jiechen Yu
Bin Liu
Lijuan Jiao
Xuefei Liu
Shuyi Yin
Jie Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.763151

4,639 views
12 citations

Review

Published on 16 Dec 2021

Treatment of AML Relapse After Allo-HCT

in Hematologic Malignancies

Jonathan A. Webster
Leo Luznik
Ivana Gojo

Frontiers in Oncology

doi 10.3389/fonc.2021.812207

23,626 views
35 citations

Original Research

Published on 16 Dec 2021

Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study

in Hematologic Malignancies

Xue Shi
Xiaoqian Liu
Xiaomei Li
Yahan Li
Dongyue Lu
Xue Sun
Ying Li
Shunfeng Hu
Yuanfeng Zhang
Xiangxiang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.754964

7,603 views
15 citations

Review

Published on 16 Dec 2021

Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective

in Hematologic Malignancies

Marwan Kwok
Catherine J. Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.790004

12,986 views
16 citations

Editorial

Published on 15 Dec 2021

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling

in Hematologic Malignancies

Jérôme Paggetti
Martina Seiffert
Etienne Moussay

Frontiers in Oncology

doi 10.3389/fonc.2021.820984

2,216 views

Original Research

Published on 14 Dec 2021

Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients

in Hematologic Malignancies

Peng Wang
Zhen Yang
Meng Shan
Shenqi Lu
Luwei Zhang
Shijia Li
Shuhong Hu
Hong Tian
Yang Xu
Depei Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.803994

10,982 views
12 citations

Mini Review

Published on 13 Dec 2021

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

in Hematologic Malignancies

Konstantinos Liapis
Ioannis Kotsianidis

Frontiers in Oncology

doi 10.3389/fonc.2021.801524

12,653 views
11 citations

Case Report

Published on 13 Dec 2021

Successful Outcome of Patellectomy Plus Chemotherapy for Primary Bone Lymphoma of the Patella: A Case Report and Literature Review

in Hematologic Malignancies

Xin Cao
Hui-Jin Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.786495

2,039 views
3 citations

Case Report

Published on 13 Dec 2021

Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?

in Hematologic Malignancies

Stefania Gaspari
Valentina Di Ruscio
Francesca Stocchi
Roberto Carta
Marco Becilli
Maria Antonietta De Ioris

Frontiers in Oncology

doi 10.3389/fonc.2021.794498

3,490 views
7 citations

Original Research

Published on 09 Dec 2021

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement

in Hematologic Malignancies

Yang Li
Yanze Cao
Mingxin Zheng
Jiaqi Hu
Wei Yan
Xiaoyu Liu
Aijun Liao
Wei Yang
Jian Li
Huihan Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.758502

2,399 views
2 citations

Review

Published on 09 Dec 2021

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

in Hematologic Malignancies

Lina van der Straten
Paul J. Hengeveld
Arnon P. Kater
Anton W. Langerak
Mark-David Levin

Frontiers in Oncology

doi 10.3389/fonc.2021.780085

9,542 views
9 citations

2,071 articles

articles

Integrated Transcriptomic Analysis Reveals a Distinctive Role of YAP1 in Extramedullary Invasion and Therapeutic Sensitivity of Multiple Myeloma

Initial Treatment Patterns and Survival Outcomes of Mantle Cell Lymphoma Patients Managed at Chinese Academic Centers in the Rituximab Era: A Real-World Study

Therapeutic Effect of CAOLD Chemotherapy Regimen on Patients With Relapsed/Refractory Angioimmunoblastic T-Cell Lymphoma: A Case Study

The Elephant in The Room: AML Relapse Post Allogeneic Hematopoietic Cell Transplantation

Retraction: MicroRNA-27 Inhibits Autophagy and Promotes Proliferation of Multiple Myeloma Cells by Targeting the NEDD4/Notch1 Axis

Case Report: Opposite Effects of BRAF Inhibition on Closely Related Clonal Myeloid Disorders

Effect of Polymorphisms of ABCB1 and MTHFR on Methotrexate-Related Toxicities in Adults With Hematological Malignancies

Case Report: Phenotypic Switch in High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements: A Potential Mechanism of Therapeutic Resistance in Lymphoma?

The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia

Aspartate β-Hydroxylase (ASPH) Expression in Acute Myeloid Leukemia: A Potential Novel Therapeutic Target

Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World

The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia

Prognostic Value and Outcome for ETV6/RUNX1-Positive Pediatric Acute Lymphoblastic Leukemia: A Report From the South China Children’s Leukemia Group

SAMHD1 Mutations and Expression in Mantle Cell Lymphoma Patients

Treatment of AML Relapse After Allo-HCT

Risk Stratification for Diffuse Large B-Cell Lymphoma by Integrating Interim Evaluation and International Prognostic Index: A Multicenter Retrospective Study

Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Disease Biology and Signaling

Maternal and Fetal Outcomes of Acute Leukemia in Pregnancy: A Retrospective Study of 52 Patients

Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?

Successful Outcome of Patellectomy Plus Chemotherapy for Primary Bone Lymphoma of the Patella: A Case Report and Literature Review

Case Report: Early Association of Vemurafenib to Standard Chemotherapy in Multisystem Langerhans Cell Histiocytosis in a Newborn: Taking a Chance for a Better Outcome?

Nomogram Model for Dynamic and Individual Prediction of Cardiac Response and Survival for Light Chain Amyloidosis in 737 Patients With Cardiac Involvement

Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features